Today, the AB Nexus program announced its fourth round of grant awards to faculty from the University of Colorado Anschutz Medical Campus and the University of Colorado Boulder. From advancing new cancer and diabetes treatments to developing AI tools to diagnose dementia, the selected teams bring together experts from multiple disciplines to advance basic science and translational research that improves human health and well-being.
Researchers from the University of Colorado Anschutz Medical Campus have established a new framework for understanding how classic antidepressants work in treating major depressive disorder (MDD), reemphasizing their importance and aiming to reframe clinical conversation […]
The statistics are sobering: Cardiovascular disease is the No. 1 killer of women in the United States, taking the life of one in three women. Additionally, nearly 45% of women ages 20 and over are […]
On Aug. 18, alumni, friends, faculty and staff gathered on campus for the fifth Loyal Benefactor Celebration. This event honors those who make ongoing annual gifts to support the university, those who have included the […]
Copyright © 2026 Biotech Networks
